MedPath

Effect of Two Iron Preparations on Protein in the Urine

Phase 4
Completed
Conditions
Kidney Failure, Chronic
Anemia, Iron-Deficiency
Interventions
Drug: Sodium Ferric Gluconate and Iron sucrose
Registration Number
NCT00354692
Lead Sponsor
Watson Pharmaceuticals
Brief Summary

This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Moderate to severe anemia
  • Iron deficiency
  • Moderate to severe chronic kidney disease
  • Age ≥ 18 or greater and able to give informed consent
Exclusion Criteria
  • Receiving dialysis
  • Known sensitivity to Sodium Ferric Gluconate Complex in Sucrose Injection, Iron sucrose USP, or any of their components
  • Clinically unstable
  • Indication of iron sufficiency

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ExperimentalSodium Ferric Gluconate and Iron sucrose-
Primary Outcome Measures
NameTimeMethod
Change in urine protein180 minutes
Secondary Outcome Measures
NameTimeMethod
Change in various urine chemicals180 minutes
© Copyright 2025. All Rights Reserved by MedPath